A detailed history of Continuum Advisory, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 4,112 shares of ZTS stock, worth $800,853. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,112
Previous 3,950 4.1%
Holding current value
$800,853
Previous $668,000 6.59%
% of portfolio
0.1%
Previous 0.1%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$145.54 - $178.83 $23,577 - $28,970
162 Added 4.1%
4,112 $712,000
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $100,230 - $120,963
605 Added 18.09%
3,950 $668,000
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $25,896 - $34,215
171 Added 5.39%
3,345 $660,000
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $7,688 - $8,867
-46 Reduced 1.43%
3,174 $552,000
Q2 2023

Dec 13, 2023

BUY
$160.94 - $186.23 $17,703 - $20,485
110 Added 3.54%
3,220 $554,000
Q2 2023

Aug 10, 2023

BUY
$160.94 - $186.23 $17,703 - $20,485
110 Added 3.54%
3,220 $554,000
Q1 2023

Dec 13, 2023

SELL
$145.48 - $175.02 $5,964 - $7,175
-41 Reduced 1.3%
3,110 $517,000
Q1 2023

May 12, 2023

SELL
$145.48 - $175.02 $5,964 - $7,175
-41 Reduced 1.3%
3,110 $517,000
Q4 2022

Dec 13, 2023

SELL
$131.14 - $157.47 $43,931 - $52,752
-335 Reduced 9.61%
3,151 $461,000
Q4 2022

Feb 10, 2023

SELL
$131.14 - $157.47 $43,931 - $52,752
-335 Reduced 9.61%
3,151 $461,000
Q3 2022

Dec 13, 2023

SELL
$148.29 - $182.55 $101,726 - $125,229
-686 Reduced 16.44%
3,486 $516,000
Q3 2022

Nov 08, 2022

SELL
$148.29 - $182.55 $101,726 - $125,229
-686 Reduced 16.44%
3,486 $517,000
Q2 2022

Dec 13, 2023

SELL
$155.97 - $200.09 $6,394 - $8,203
-41 Reduced 0.97%
4,172 $717,000
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $6,394 - $8,203
-41 Reduced 0.97%
4,172 $717,000
Q1 2022

Dec 13, 2023

BUY
$181.39 - $234.03 $101,941 - $131,524
562 Added 15.39%
4,213 $794,000
Q1 2022

May 17, 2022

BUY
$181.39 - $234.03 $101,941 - $131,524
562 Added 15.39%
4,213 $747,000
Q4 2021

Dec 13, 2023

SELL
$193.69 - $247.03 $19,756 - $25,197
-102 Reduced 2.72%
3,651 $890,000
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $19,756 - $25,197
-102 Reduced 2.72%
3,651 $891,000
Q3 2021

Dec 13, 2023

BUY
$189.29 - $209.69 $31,990 - $35,437
169 Added 4.72%
3,753 $728,000
Q3 2021

Nov 08, 2021

BUY
$189.29 - $209.69 $31,990 - $35,437
169 Added 4.72%
3,753 $729,000
Q2 2021

Dec 13, 2023

BUY
$155.9 - $187.99 $63,919 - $77,075
410 Added 12.92%
3,584 $667,000
Q2 2021

Aug 17, 2021

BUY
$155.9 - $187.99 $558,745 - $673,756
3,584 New
3,584 $668,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $91.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.